Literature DB >> 18606503

Autosomal linkage analysis for cannabis use behaviors in Australian adults.

Arpana Agrawal1, Katherine I Morley, Narelle K Hansell, Michele L Pergadia, Grant W Montgomery, Dixie J Statham, Richard D Todd, Pamela A F Madden, Andrew C Heath, John Whitfield, Nicholas G Martin, Michael T Lynskey.   

Abstract

Cannabis is the most commonly used illicit drug in developed and in developing nations. Twin studies have highlighted the role of genetic influences on early stages of cannabis use, such as a lifetime history of use, early-onset use and frequent use, however, we are not aware of any genomic studies that have examined these phenotypes. Using data on 2314 families consisting of 5600 adult Australian offspring and their parents, all of whom were scanned using 1399 unique autosomal markers, we conducted autosomal linkage analyses for lifetime history of cannabis initiation, early-onset cannabis use and frequency of use, using a variance components approach in the linkage package MERLIN. Suggestive evidence for linkage was found on chromosome 18 (LOD 2.14 for frequency of use, LOD 1.97 for initiation, at 90-97 cM) and also on chromosome 19 (LOD 1.92 for early-onset at 17 cM). These LOD scores did not meet genome-wide significance. Further replication of these linkage regions in other samples will be required, although these initial results suggest further targeted efforts on chromosome 18 may yield interesting candidate genes for early stages of cannabis-related behaviors.

Entities:  

Mesh:

Year:  2008        PMID: 18606503      PMCID: PMC2584346          DOI: 10.1016/j.drugalcdep.2008.05.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  35 in total

1.  Improved inference of relationship for pairs of individuals.

Authors:  M P Epstein; W L Duren; M Boehnke
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.025

2.  Association analysis in a variance components framework.

Authors:  G R Abecasis; L R Cardon; W O Cookson; P C Sham; S S Cherny
Journal:  Genet Epidemiol       Date:  2001       Impact factor: 2.135

3.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

4.  Predictors of non-response to a questionnaire survey of a volunteer twin panel: findings from the Australian 1989 twin cohort.

Authors:  A C Heath; W Howells; K M Kirk; P A Madden; K K Bucholz; E C Nelson; W S Slutske; D J Statham; N G Martin
Journal:  Twin Res       Date:  2001-04

5.  Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.

Authors:  Kenneth S Kendler; Kristen C Jacobson; Carol A Prescott; Michael C Neale
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

6.  A genome-wide search for quantitative trait loci influencing substance dependence vulnerability in adolescence.

Authors:  Michael C Stallings; Robin P Corley; John K Hewitt; Kenneth S Krauter; Jeffrey M Lessem; Susan K Mikulich; Soo Hyun Rhee; Andrew Smolen; Susan E Young; Thomas J Crowley
Journal:  Drug Alcohol Depend       Date:  2003-06-05       Impact factor: 4.492

7.  Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms.

Authors:  G R Uhl; Q R Liu; D Walther; J Hess; D Naiman
Journal:  Am J Hum Genet       Date:  2001-11-06       Impact factor: 11.025

8.  Escalation of drug use in early-onset cannabis users vs co-twin controls.

Authors:  Michael T Lynskey; Andrew C Heath; Kathleen K Bucholz; Wendy S Slutske; Pamela A F Madden; Elliot C Nelson; Dixie J Statham; Nicholas G Martin
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

9.  The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women.

Authors:  Kenneth S Kendler; Carol A Prescott; John Myers; Michael C Neale
Journal:  Arch Gen Psychiatry       Date:  2003-09

10.  Long-term stability and heritability of telephone interview measures of alcohol consumption and dependence.

Authors:  Narelle K Hansell; Arpana Agrawal; John B Whitfield; Katherine I Morley; Gu Zhu; Penelope A Lind; Michele L Pergadia; Pamela A F Madden; Richard D Todd; Andrew C Heath; Nicholas G Martin
Journal:  Twin Res Hum Genet       Date:  2008-06       Impact factor: 1.587

View more
  5 in total

1.  Linkage analyses of stimulant dependence, craving, and heavy use in American Indians.

Authors:  Cindy L Ehlers; Ian R Gizer; David A Gilder; Kirk C Wilhelmsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-02       Impact factor: 3.568

2.  Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans.

Authors:  Shizhong Han; Bao-Zhu Yang; Henry R Kranzler; David Oslin; Raymond Anton; Lindsay A Farrer; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2012-04-19       Impact factor: 13.382

3.  Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study.

Authors:  Cindy L Ehlers; Ian R Gizer; Cassandra Vieten; Kirk C Wilhelmsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

4.  Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset.

Authors:  Camelia C Minică; Conor V Dolan; Jouke-Jan Hottenga; René Pool; Iryna O Fedko; Hamdi Mbarek; Charlotte Huppertz; Meike Bartels; Dorret I Boomsma; Jacqueline M Vink
Journal:  Behav Genet       Date:  2015-05-19       Impact factor: 2.805

5.  Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium.

Authors:  S Stringer; C C Minică; K J H Verweij; H Mbarek; M Bernard; J Derringer; K R van Eijk; J D Isen; A Loukola; D F Maciejewski; E Mihailov; P J van der Most; C Sánchez-Mora; L Roos; R Sherva; R Walters; J J Ware; A Abdellaoui; T B Bigdeli; S J T Branje; S A Brown; M Bruinenberg; M Casas; T Esko; I Garcia-Martinez; S D Gordon; J M Harris; C A Hartman; A K Henders; A C Heath; I B Hickie; M Hickman; C J Hopfer; J J Hottenga; A C Huizink; D E Irons; R S Kahn; T Korhonen; H R Kranzler; K Krauter; P A C van Lier; G H Lubke; P A F Madden; R Mägi; M K McGue; S E Medland; W H J Meeus; M B Miller; G W Montgomery; M G Nivard; I M Nolte; A J Oldehinkel; Z Pausova; B Qaiser; L Quaye; J A Ramos-Quiroga; V Richarte; R J Rose; J Shin; M C Stallings; A I Stiby; T L Wall; M J Wright; H M Koot; T Paus; J K Hewitt; M Ribasés; J Kaprio; M P Boks; H Snieder; T Spector; M R Munafò; A Metspalu; J Gelernter; D I Boomsma; W G Iacono; N G Martin; N A Gillespie; E M Derks; J M Vink
Journal:  Transl Psychiatry       Date:  2016-03-29       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.